| Expression pattern: |
DN |
| Associated gene: |
NST, MLN |
| Associated microRNA: |
miR-19a |
| Biological function: |
Overexpression of circORC2 exerts a beneficial effect in STC by up-regulating neurotensin and motilin via suppressing miR-19a. |
| Molecular mechanism: |
circORC2 sponges miR-19a; miR-19a targets MLN and NST mRNAs; circORC2 up-regulates MLN and NST by down-regulating miR-19a. |
| Biological pathway or process: |
ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis; Luciferase Reporter Assay; Transfection; Western Blot |
| Clinical significance: |
circORC2 level was lowest in the STC group (vs HC/NTC), suggesting association with STC status; overexpression could be beneficial for STC treatment. |
| Description: |
In STC patients, circORC2 is down-regulated in peripheral blood. circORC2 acts as a miR-19a sponge, relieving miR-19a-mediated repression of MLN and NST, thereby increasing motilin and neurotensin signaling that may benefit STC. |
| Confidence score: |
0.6102 |